Tatva Chintan Pharma
Chem Limited IPO
Open for Subscription

India Pesticides Limited IPO
`1073 -

Why subscribe to Tatva Chintan Pharma Chem Limited?

Tatva Chintan Pharma Chem limited is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (“PASC”). The company is the largest and only commercial manufacturer of SDAs for zeolites in India while being the second largest globally. Tatva Chintan Pharma Chem is also one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. The company’s products find their use in automotive, petroleum, pharmaceutical, agro chemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries.

Objects of the Offer: The offer comprises of a fresh issue and an offer for sale. The fresh issue is of ₹ 225cr out of which ₹ 147.1cr would be used for capital expenditure requirements for expansion of the company’s Dahej manufacturing facility and ₹ 23.97cr would be used for upgrading their R&D facility in Vadodara. The remaining proceeds from the fresh issue would be used for General corporate purposes. The offer for sale is comprised of ₹ 275cr, the proceeds of which would be given to the selling shareholders and no part of it would be given to the company.

Click here for complete report.

New Customer?
Open IIFL Demat Account


If You Are An Existing

Click To Invest

Subscribe now

Issue Highlights

  • 16-July-21
  • 20-July-21
  • ` 1073 - ` 1083 per share
  • ` 10 per equity share
  • ` 500 crores
  • Bombay Stock Exchange
    & National Stock Exchange
  • 50%
  • 15%
  • 35%